RPL38P3

Across TCGA pan-cancer cohorts, RPL38P3 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL38P3 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RPL38P3 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL38P3 expression acts as an unfavorable survival marker, although some lineages such as CESC and HNSC show a favorable association.

CESC, HNSC, and THCA are the cancer types where RPL38P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	III,IV	1.000	0.303	.011	60	view →
HNSC	OS	Tertile	IV	0.726	0.319	.006	33	view →
THCA	DFS	Tertile	III,IV	0.474	0.808	.002	27	view →
KIRC	OS	Tertile	All	0.505	0.648	.020	24	view →
OV	DFS	Tertile	IV	0.542	0.291	.019	20	view →
DLBC	OS	Quartile	II,III,IV	0.096	0.865	.001	20	view →
LIHC	OS	Tertile	III,IV	0.051	0.738	<.001	18	view →
BRCA	DFS	Tertile	All	0.371	0.557	.007	15	view →
THYM	DFS	Quartile	All	0.587	0.870	.017	12	view →
SKCM	OS	Quartile	III,IV	0.654	0.883	.004	10	view →
COAD	OS	Tertile	All	0.948	0.845	.040	9	view →
LGG	DFS	Tertile	All	0.729	0.405	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL38P3–CESC (DFS)

Open the CESC breakdown →